3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Phase 1
1
Status
Terminated
3
Recruiting
2
Unknown
1
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
145
Carcinoma, Non-Small-Cell Lung
97
Colorectal Neoplasms
96
Carcinoma, Hepatocellular
69
Stomach Neoplasms
65
Rectal Neoplasms
54
Neoplasms
53
Lung Neoplasms
44
Prostatic Neoplasms
41
Colonic Neoplasms
41
Leukemia, Myeloid, Acute
40
Nasopharyngeal Carcinoma
39
Lymphoma, Large B-Cell, Diffuse
39
Uterine Cervical Neoplasms
37
Esophageal Neoplasms
33
Ovarian Neoplasms
32
Neoplasm Metastasis
32
Multiple Myeloma
31
Lymphoma
31
Lymphoma, Follicular
30
Leukemia
28
Pancreatic Neoplasms
27
Recurrence
23
Head and Neck Neoplasms
22
Brain Neoplasms
21
Urinary Bladder Neoplasms
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Lymphoma, Non-Hodgkin
19
Lymphoma, Mantle-Cell
18
Squamous Cell Carcinoma of Head and Neck
17
Interventions
Vinorelbine
1
Pemetrexed
1
Gemcitabine
1
Docetaxel
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Unknown
×
Respiratory Tract Neoplasms
×
Clear all
NCT03402048
2020-11-04
EPIC
University of Turin, Italy
Phase 3
Unknown
567 enrolled